SPARC Secures Stock Exchange Approvals for Promoter Group Reclassification to Public
Sun Pharma Advanced Research Company Ltd 路 Others (Uncategorized) 路 12 Nov 2026, 10:59 pm
SPARC Secures Stock Exchange Approvals for Promoter Group Reclassification to Public Sun Pharma Advanced Research Company Ltd. (SPARC) received No-Objection Letters dated 12th Nov'26 from both NSE and BSE regarding the reclassification of certain individuals from the 'Promoter Group' category to the 'Public' category under Regulation 31A of SEBI LODR Regulations. The approved reclassification covers Krishna Vrundavandas Valia, Sudhir Vrundavandas Valia, and Raksha Sudhir Valia, pursuant to the company's application submitted on 13th Aug'26.
Original exchange filing (PDF)
More announcements from Sun Pharma Advanced Research Company Ltd
- Response of Clarification sought from BSE Limited 路 11 Nov 2026
- The Exchange has sought clarification from Sun Pharma Advanced Research Company Ltd on November 11, 2026, with reference to Movement in Volume. <BR><BR>The reply is awaited. 路 11 Nov 2026
- Monitoring Agency Report for the quarter ended September 30, 2026 路 03 Nov 2026
- Financial Results for the quarter and half year ended September 30, 2026 路 03 Nov 2026
- Sun Pharma Advanced Research Company Limited has submitted to the Exchange, the unaudited financial results for the quarter and half year ended September 30, 2026. 路 03 Nov 2026
- Sun Pharma Advanced Research Company Limited has informed the Exchange about Board Meeting to be held on 02-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 02 Nov 2026
- To consider and approve the financial results for the quarter and half year ended September 30, 2026 路 02 Nov 2026
- Sun Pharma Advanced Research Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 ,inter alia, to consider and approve unaudited .... 路 02 Nov 2026
